Profilo
Sheng Fu Liao is currently a Director-Supervisory Board at Yue Chang Investment Co. Ltd., Innova Health Care, Inc., and Innova Vision KK.
Previously, he served as a Director-Supervisory Board at Innova Vision Inc. He also worked as a Manager-Finance at Taiwan Mask Corp.
from 1999 to 2018.
Additionally, he was a Member-Supervisory Board at Advagene Biopharma Co., Ltd. from 2016 to 2019.
Mr. Liao is a graduate of National Cheng Kung University.
Posizioni attive di Sheng Fu Liao
| Società | Posizione | Inizio |
|---|---|---|
Innova Vision KK | Direttore/Membro del Consiglio | 17/02/2011 |
Innova Health Care, Inc. | Direttore/Membro del Consiglio | 17/02/2011 |
Yue Chang Investment Co. Ltd. /Taiwanmask/ | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Sheng Fu Liao
| Società | Posizione | Fine |
|---|---|---|
| ADVAGENE BIOPHARMA CO., LTD. | Direttore/Membro del Consiglio | 23/05/2019 |
| TAIWAN MASK CORPORATION | Direttore Finanziario/CFO | 15/01/2018 |
Innova Vision Inc.
Innova Vision Inc. Medical SpecialtiesHealth Technology Manufactures medical equipment | Direttore/Membro del Consiglio | - |
Formazione di Sheng Fu Liao
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
Taiwan Mask Corp.
Taiwan Mask Corp. SemiconductorsElectronic Technology Designs, manufactures and distributes reticles & photomasks | Electronic Technology |
Yue Chang Investment Co. Ltd. /Taiwanmask/ | |
National Cheng Kung University
National Cheng Kung University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Innova Vision Inc.
Innova Vision Inc. Medical SpecialtiesHealth Technology Manufactures medical equipment | Health Technology |
Innova Health Care, Inc. | |
Innova Vision KK | |
Advagene Biopharma Co., Ltd.
Advagene Biopharma Co., Ltd. BiotechnologyHealth Technology Engages in the development of products such as nasal influenza vaccine, airway allergy immunotherapy and COVID-19 immunotherapy | Health Technology |
















